177 related articles for article (PubMed ID: 37596322)
1. AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
Wan S; Liu C; Li C; Wang Z; Zhao G; Li J; Ran W; Zhong X; Li Y; Zhang L; Cui H
Oncogene; 2023 Sep; 42(39):2905-2918. PubMed ID: 37596322
[TBL] [Abstract][Full Text] [Related]
2. The role of A-kinase interacting protein 1 in regulating progression and stemness as well as indicating the prognosis in glioblastoma.
Tang J; Peng S; Yan H; Ni M; Hou X; Ma P; Li Y
Transl Oncol; 2022 Aug; 22():101463. PubMed ID: 35691247
[TBL] [Abstract][Full Text] [Related]
3. Silencing of AKIP1 Suppresses the Proliferation, Migration, and Epithelial-Mesenchymal Transition Process of Glioma Cells by Upregulating DLG2.
Chen Z; Wen H; Zhang J; Zou X; Wu S
Biomed Res Int; 2022; 2022():5648011. PubMed ID: 35111846
[TBL] [Abstract][Full Text] [Related]
4. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
Zhang X; Liu S; Zhu Y
Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
[TBL] [Abstract][Full Text] [Related]
5. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
[TBL] [Abstract][Full Text] [Related]
6. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma.
Lin C; Song L; Liu A; Gong H; Lin X; Wu J; Li M; Li J
Oncogene; 2015 Jan; 34(3):384-93. PubMed ID: 24413079
[TBL] [Abstract][Full Text] [Related]
8. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
9. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
Shen S; Yao Y
Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
[TBL] [Abstract][Full Text] [Related]
10. AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.
Zhang W; Wu Q; Wang C; Yang L; Liu P; Ma C
Mol Cell Biochem; 2018 Nov; 448(1-2):311-320. PubMed ID: 29520695
[TBL] [Abstract][Full Text] [Related]
11. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
12. EGFR-ERK pathway regulates CSN6 to contribute to PD-L1 expression in glioblastoma.
Su L; Guo W; Lou L; Nie S; Zhang Q; Liu Y; Chang Y; Zhang X; Li Y; Shen H
Mol Carcinog; 2020 May; 59(5):520-532. PubMed ID: 32134157
[TBL] [Abstract][Full Text] [Related]
13. CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.
Peng W; Shi S; Zhong J; Liang H; Hou J; Hu X; Wang F; Zhang J; Geng S; Sun X; Zhong D; Cui H
Oncogene; 2022 May; 41(22):3051-3063. PubMed ID: 35459780
[TBL] [Abstract][Full Text] [Related]
14. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways.
Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L
Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353
[TBL] [Abstract][Full Text] [Related]
15. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
[TBL] [Abstract][Full Text] [Related]
17. FHL2 interacts with EGFR to promote glioblastoma growth.
Sun L; Yu S; Xu H; Zheng Y; Lin J; Wu M; Wang J; Wang A; Lan Q; Furnari F; Cavenee W; Purow B; Li M
Oncogene; 2018 Mar; 37(10):1386-1398. PubMed ID: 29321665
[TBL] [Abstract][Full Text] [Related]
18. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
[TBL] [Abstract][Full Text] [Related]
19. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling.
Gao N; Hibi Y; Cueno M; Asamitsu K; Okamoto T
J Biol Chem; 2010 Sep; 285(36):28097-104. PubMed ID: 20562110
[TBL] [Abstract][Full Text] [Related]
20. LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling.
Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
Int J Oncol; 2018 Sep; 53(3):1069-1082. PubMed ID: 30015847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]